We sought to investigate whether demethylation by another epigenetic modifying agent, 5-aza-2′-deoxycytidine (Decitabine, DAC), could modulate expression of full length RON and its isoforms in pancreatic cancer cells. Here, MST1R is linked to familial pancreatic carcinoma.